{"id":558,"date":"2014-09-18T09:27:55","date_gmt":"2014-09-18T16:27:55","guid":{"rendered":"http:\/\/worldmedicalinnovation.org\/?page_id=558"},"modified":"2016-05-16T12:13:57","modified_gmt":"2016-05-16T16:13:57","slug":"agenda","status":"publish","type":"page","link":"http:\/\/medforum16.sitedistrict.com\/agenda\/","title":{"rendered":"Agenda"},"content":{"rendered":"<div class='css-events-list'><h3 id=\"Monday, April 25, 2016\">Monday, April 25, 2016<\/h3><span id=\"2016-04-25\" rel=\"m_PageScroll2id\"><\/span> \n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>7:00 am - 8:00 am<\/b><br \/>Ipsen Foyer<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/continental-breakfast-2\/\">Continental Breakfast<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>7:00 am - 8:00 am<\/b><br \/>Ipsen Foyer<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/registration-opens\/\">Registration Opens<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>8:00 am - 12:00 pm<\/b><br \/>Takeda Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/first-look-the-next-wave-of-cancer-breakthroughs\/\">First Look: The Next Wave of Cancer Breakthroughs<\/a><\/h5>\n<p>Highly creative young investigators describe their most promising commercially<br \/>\nrelated research. Rapid-fire presentations by two dozen early-career Harvard<br \/>\nMedical School faculty will highlight compelling new discoveries and insights that<br \/>\nwill be the cancer care products of the future. These young stars from Brigham and<br \/>\nWomen&#8217;s Hospital, Massachusetts General Hospital and Dana-Farber Cancer<br \/>\nInstitute will each describe their work in highly organized 10-minute sessions. This<br \/>\nsession will take place in the Takeda Ballroom. Presenters will be available<br \/>\nimmediately following their talk in the third floor GE Foyer.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>12:00 pm - 1:30 pm<\/b><br \/>Bristol-Myers Squibb Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/discovery-cafe-enjoy-lunch-with-top-cancer-leadership-from-across-partners-healthcare\/\">Discovery Caf\u00e9: Enjoy Lunch with Top Cancer Leadership from across Partners HealthCare<\/a><\/h5>\n<p>Top Harvard Medical School faculty from Brigham and Women&#8217;s Hospital,<br \/>\nMassachusetts General Hospital and Dana-Farber Cancer Institute will host intimate<br \/>\nlunch discussions on developments in their field and their own research. These<br \/>\ninternationally renowned leaders will engage on cutting edge research and new<br \/>\ntrends in their clinical and research domain. Seating is reserved based on prior<br \/>\nregistration. Please check at registration to find if there is open table availability.<\/p>\n<p>A complete list of table hosts and topics is available here:\u00a0<a href=\"http:\/\/worldmedicalinnovation.org\/highlights\/\">http:\/\/worldmedicalinnovation.org\/highlights\/<\/a><\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>1:45 pm - 1:55 pm<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/anne-klibanski-md\/\">Forum Opening and Announcements<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Introduction by: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/anne-klibanski-md\/\">Anne Klibanski, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chief Academic Officer, Partners HealthCare<\/li><li>Laurie Carrol Guthart Professor of Medicine, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/david-torchiana-md\/\">David Torchiana, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Partners HealthCare<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>1:55 pm - 2:20 pm<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/monica-bertagnolli-md\/\">A War or Moonshot: Where Do We Stand?<\/a><\/h5>\n<p>Forum Co-Chairs Dr. Bertagnolli and Haber provide perspectives on the coming era<br \/>\nof cancer research and care.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/nancy-l-snyderman-md\/\">Nancy Snyderman, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Medical Advisor, GE Healthymagination<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/monica-bertagnolli-md\/\">Monica Bertagnolli, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chief, Division of Surgical Oncology, Brigham and Women's Hospital<\/li><li>Professor of Surgery, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/daniel-haber-phd-md\/\">Daniel Haber, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Director, MGH Cancer Center<\/li><li>Kurt J. Isselbacher \/Peter D. Schwartz Professor of Oncology, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>2:20 pm - 3:10 pm<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/robert-tepper-md\/\">Creating a Disruptive Cancer Pipeline<\/a><\/h5>\n<p>Some companies characterize creating a successful pipeline of disruptive cancer<br \/>\ntherapies as an engineering challenge, others describe arranging building blocks or<br \/>\nintegrating capabilities from the marketplace \u2013 for many it is all of the above.<br \/>\nConsiderations include discovering novel targets, novel single agent drugs and<br \/>\nemerging novel mechanisms, new pathways and\/or mechanisms of action, new<br \/>\nmolecular entities and technology acquisition strategies, among others. The panel,<br \/>\ncorporate officers, investors and academic experts pulls back the curtain to discuss<br \/>\nthe considerations in pipeline development, the tradeoffs and what it takes to<br \/>\nmaintain success over time.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/robert-tepper-md\/\">Robert Tepper, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Partner, Third Rock Ventures<\/li><li>Adjunct Professor, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/james-bradner-md\/\">James Bradner, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>President, Novartis Institutes for BioMedical Research<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/george-demitri-md\/\">George Demetri, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Director, Center for Sarcoma and Bone Oncology, Senior Vice President for Experimental Therapeutics, Institute Physician, Dana-Farber Cancer Institute<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/steve-fawell-phd\/\">Steve Fawell, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>VP, Head Oncology iScience, AstraZeneca<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/keith-flaherty-md\/\">Keith Flaherty, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Director, Clinical Research, MGH Cancer Center<\/li><li>Associate Professor of Medicine, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/sean-harper\/\">Sean Harper, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Executive Vice President, Research and Development, Amgen<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>3:10 pm - 4:00 pm<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/peter-slavin-md\/\">Curative Therapies: The Economics of Game Changing Science<\/a><\/h5>\n<p>Novel, potentially curative, cancer therapies are coming to market. Recent<br \/>\nexperience in Hepatitis C therapy raises the question as to whether a new approach<br \/>\nis needed to design a pricing model that better balances resulting cost pressure<br \/>\nacross the delivery system. While most acknowledge systemic cost effectiveness<br \/>\ncurative therapies also present many challenges to payers \u2013 e.g. a spike in patient<br \/>\nvolume and cost as these therapies are introduced. A broad ranging dialogue<br \/>\nhas emerged in the cancer community that includes incorporating cost<br \/>\neffectiveness as part of the regulatory approval, shifting incentives for oncologists,<br \/>\nincreasing emphasis on early detection, integrating billing codes, bundled<br \/>\npayments and management fees and many others. The panel with top executives<br \/>\nfrom the pharma, foundation, pharmacy and provider sectors will share insights on<br \/>\nthis crucially important topic.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Introduction by: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/gregg-meyer-md\/\">Gregg Meyer, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chief Clinical Officer, Partners Healthcare System<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/sue-siegel\/\">Sue Siegel<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, GE Ventures and Healthymagination<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/troyan-brennan-md\/\">Troyen Brennan, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Executive Vice President and CMO, CVS Health<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/paul-hudson\/\">Paul Hudson<\/a><\/div><div class=\"speaker-meta\"><ul><li>President, AstraZeneca US<\/li><li>Executive Vice President, AstraZeneca North America<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/betsy-nabel-md\/\">Betsy Nabel, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>President, Brigham and Women's Hospital<\/li><li>Professor of Medicine, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/gary-reedy\/\">Gary Reedy<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, American Cancer Society<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/peter-slavin-md\/\">Peter Slavin, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>President, Massachusetts General Hospital<\/li><li>Professor of Healthcare Policy, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>4:00 pm - 4:50 pm<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/briggs-morrison-md\/\">Winning Portfolio Strategy<\/a><\/h5>\n<p>The many considerations involved in managing a cancer portfolio are among the<br \/>\nmost important for company vitality and also play a principal role in determining<br \/>\nthe breadth and rate that new therapies reach patients. Considerations include<br \/>\ndrug categories (current or potential), use of approved drugs on new tumor<br \/>\ntypes, product life extension, concentrating on call point strengths vs broadening<br \/>\ninto new cancers, technology category strength \u2013 e.g. small molecule vs emerging<br \/>\nones like CAR-T, product lifecycle status, competitive agents, possible portfolio<br \/>\nswaps (e.g. NVS\/GSK) and shareholder scrutiny . Panel members from the highest<br \/>\nranks of the industry &#8212; large and emerging companies &#8212; will discuss their strategic<br \/>\napproach to balancing considerations they can influence and those that they can\u2019t.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/thomas-lynch-md\/\">Thomas Lynch, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Mass General Physician's Organization<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/francis-cuss-3\/\">Francis Cuss, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Executive Vice President and Chief Scientific Officer, R&D, Bristol-Myers Squibb<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/peter-lebowitz-md-phd-global-therapeutic-area-head-oncology-janssen-rd\/\">Peter Lebowitz, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Global Therapeutic Area Head, Oncology, Janssen R&D<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/briggs-morrison-md\/\">Briggs Morrison, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Syndax Pharmaceuticals<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/alessandro-riva-md\/\">Alessandro Riva, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Global Head, Oncology Development and  Medical Affairs, Novartis Oncology<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/phil-rowlands-phd\/\">Phil Rowlands, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Interim Head, Oncology, Therapeutic Area Unit, Takeda<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>4:50 pm - 5:40 pm<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/massimo-loda-md\/\">Early Detection and Prevention of Cancer<\/a><\/h5>\n<p>The prevention of cancer and the development of new strategies to detect cancer<br \/>\nprecursors and early-stage malignancies when treatment may be most effective<br \/>\n\u2013 clinically and financially \u2014 are critical research goals. Our panel of experts reviews<br \/>\npowerful imaging modalities, single-cell analysis of the tumor microenvironment<br \/>\nand next-generation cancer models. Circulating tumor DNA testing to monitor<br \/>\nresponse to treatment and emergence of cancer resistance\u2014with the objective of<br \/>\nearly cancer diagnosis before symptoms appear\u2014will also be detailed.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/david-louis-md\/\">David Louis, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Pathologist-in-Chief, Massachusetts General Hospital<\/li><li>Benjamin Castleman Professor of Pathology, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/andy-chan-md\/\">Andy Chan, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Program Director, Gastroenterology Training Program, Massachusetts General Hospital<\/li><li>Associate Professor of Medicine, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/william-hait-md-phd\/\">William Hait, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Global Head, Janssen Research & Development<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/krishna-kumar-ceo-emerging-businesses-philips\/\">Krishna Kumar<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Emerging Businesses, Philips<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/massimo-loda-md\/\">Massimo Loda, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Senior Pathologist, Principal Investigator, Brigham and Women's Hospital, Dana-Farber Cancer Institute<\/li><li>Professor, Department of Pathology, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>5:45 pm - 5:55 pm<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/attendee-announcement\/\">Innovation Break: Announcing the C&sup3; Prize from Astellas Oncology and the World Medical Innovation Forum<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>5:55 pm - 6:45 pm<\/b><br \/>Takeda Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/welcome-reception-2\/\">Ropes &amp; Gray Welcome Reception<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>6:45 pm - 8:10 pm<\/b><br \/>Bristol-Myers Squibb Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/nancy-l-snyderman-md\/\">Ropes &amp; Gray Dinner Program - Remarks by Greg Simon, Executive Director, The White House Moonshot Initiative and Fireside Chat: Richard Gonzalez, CEO, AbbVie<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Introduction by: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/ed-lawrence\/\">Ed Lawrence<\/a><\/div><div class=\"speaker-meta\"><ul><li>Retired Partner, Ropes & Gray<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/nancy-l-snyderman-md\/\">Nancy Snyderman, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Medical Advisor, GE Healthymagination<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/richard-gonzalez\/\">Richard Gonzalez<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, AbbVie<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/greg-simon\/\">Greg Simon<\/a><\/div><div class=\"speaker-meta\"><ul><li>Executive Director, Cancer Moonshot Task Force - The White House<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n<h3 id=\"Tuesday, April 26, 2016\">Tuesday, April 26, 2016<\/h3><span id=\"2016-04-26\" rel=\"m_PageScroll2id\"><\/span> \n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>7:30 am - 8:30 am<\/b><br \/>Ipsen Foyer<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/continental-breakfast\/\">Continental Breakfast<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>8:10 am - 8:15 am<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/chris-coburn\/\">Opening<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/chris-coburn\/\">Chris Coburn<\/a><\/div><div class=\"speaker-meta\"><ul><li>Vice President, Innovation, Partners HealthCare<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>8:15 am - 9:05 am<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/bruno-strigini\/\">Global Cancer Markets<\/a><\/h5>\n<p>Cancer causes 1 in 7 deaths worldwide. If rates don\u2019t change, the global cancer<br \/>\nburden is expected to increase from 14 million new cases and 8 million cancer<br \/>\nrelated deaths worldwide to 22 million cases and 13 million deaths by 2030. The<br \/>\npanel will discuss how approaches to deliver innovative technologies differ in<br \/>\ndifferent international markets, what the respective drivers are, as well as<br \/>\nrequirements and challenges. Expert panelists from leading international<br \/>\ncompanies and key governmental entities, including the famed NICE from the UK<br \/>\nNHS, will consider strategies and key trends.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/sheila-dharmarajan\/\">Sheila Dharmarajan<\/a><\/div><div class=\"speaker-meta\"><ul><li>Head of Business Development, Zelnick Media Capital<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/newton-crenshaw\/\">Newton Crenshaw<\/a><\/div><div class=\"speaker-meta\"><ul><li>Vice President of North America Oncology, Eli Lilly and Company<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/marc-de-garidel\/\">Marc de Garidel<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chairman and CEO, Ipsen<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/gillian-leng-md\/\">Gillian Leng, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Deputy Chief Executive, Director of Health and Social Care, National Institute for Health and Care Excellence<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/james-robinson\/\">James Robinson<\/a><\/div><div class=\"speaker-meta\"><ul><li>President, Americas Operations, Astellas<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/bruno-strigini\/\">Bruno Strigini<\/a><\/div><div class=\"speaker-meta\"><ul><li>President, Novartis Oncology<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>9:05 am - 9:55 am<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/johnathan-whetstine-phd\/\">Epigenetics and Novel Cancer Targets<\/a><\/h5>\n<p>The initiation and progression of cancer is controlled by both genetic and<br \/>\nepigenetic events. Epigenetics, the study of changes that influence how DNA<br \/>\ndoes its job, is one of the fastest-moving fields in cancer research. Expert corporate<br \/>\nand academic panel members will discuss the promise of epigenetics. They will<br \/>\ndescribe translating basic epigenetic research into cancer diagnostics and<br \/>\ntherapies, emphasizing market opportunities and competitive advantages.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/pat-fortune-phd\/\">Pat Fortune, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Senior Market Sector Leader, Partners Innovation<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/robert-copeland-phd\/\">Robert Copeland, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>President of Research and Chief Scientific Officer, Epizyme<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/keith-dionne-phd\/\">Keith Dionne, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Constellation Pharmaceuticals, Inc.<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/cigall-kadoch-phd\/\">Cigall Kadoch, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Assistant Professor, Dana-Farber Cancer Institute, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/jeannie-lee-phd-md\/\">Jeannie Lee, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Professor of Genetics, Massachusetts General Hospital<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/nancy-simonian-md\/\">Nancy Simonian, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Syros Pharmaceuticals<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/johnathan-whetstine-phd\/\">Johnathan Whetstine, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Tepper Family MGH Research Scholar<\/li><li>Associate Professor of Medicine, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>9:55 am - 10:25 am<\/b><br \/>Ipsen Foyer<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/networking-break\/\">Networking Break<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>10:25 am - 11:05 am<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/robert-bradway\/\">Fireside Chat: Robert Bradway, CEO, Amgen<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Introduction by: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/cathy-minehan\/\">Cathy Minehan<\/a><\/div><div class=\"speaker-meta\"><ul><li>Dean, School of Management, Simmons College<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/caroline-chen\/\">Caroline Chen<\/a><\/div><div class=\"speaker-meta\"><ul><li>Reporter, Bloomberg Business<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/robert-bradway\/\">Robert Bradway<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Amgen<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>11:05 am - 12:00 pm<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/robert-mulroy\/\">Immunotherapy I: Checkpoint Activation and Cancer Vaccines<\/a><\/h5>\n<p>Among the most promising approaches to activating therapeutic antitumor<br \/>\nimmunity is the blockade of immune checkpoints. Checkpoint blockade, prevention<br \/>\nof inhibitory signaling that limits activation or function of tumor antigen-specific<br \/>\nT cells responses, is revolutionizing the treatment of many poor-prognosis<br \/>\nmalignancies. Expert panelists discuss significant long-term cancer remissions,<br \/>\npotential cures \u2013 in some cases \u2013 and how boosting the body\u2019s own defenses<br \/>\nis producing stunning results when combined with standard anticancer therapies<br \/>\nand other immunotherapies. They will also detail the experimental accines in<br \/>\ndevelopment that are designed to \u201cwake up\u201d the immune system so it will trigger<br \/>\nreliable and effective attacks on cancer cells.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/nir-hacohen-phd\/\">Nir Hacohen, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Immunologist, MGH Center for Immunology and Inflammatory Diseases, MGH Research Scholar<\/li><li>Associate Professor, Medicine, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/thomas-daniel-md\/\">Thomas Daniel, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chairman, Celgene Research<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/glenn-dranoff-md\/\">Glenn Dranoff, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Global Head of Exploratory Immuno-Oncology, Novartis Institutes for Biomedical Research<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/robert-mulroy\/\">Robert Mulroy<\/a><\/div><div class=\"speaker-meta\"><ul><li>President and CEO, Merrimack Pharmaceuticals<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/david-reese-md\/\">David Reese, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Senior Vice President, Translational Sciences, Amgen<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/scott-rodig-md-phd\/\">Scott Rodig, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Associate Professor, Brigham and Women's Hospital<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/arlene-sharpe-md-phd\/\">Arlene Sharpe, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Leader, Cancer Immunology, Brigham and Women's Hospital, Dana-Farber Cancer Institute<\/li><li>George Fabyan Professor of Comparative Pathology, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>12:00 pm - 12:30 pm<\/b><br \/>Bristol-Myers Squibb Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/lunch-2\/\">Lunch<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>12:30 pm - 1:00 pm<\/b><br \/>Bristol-Myers Squibb Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/david-torchiana-md\/\">Fireside Chat: Andy Slavitt, Acting Administrator, CMS<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Introduction by: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/david-torchiana-md\/\">David Torchiana, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Partners HealthCare<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/meg-tirrell\/\">Meg Tirrell<\/a><\/div><div class=\"speaker-meta\"><ul><li>Biotech and Pharma Reporter, CNBC<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/andy-slavitt\/\">Andy Slavitt<\/a><\/div><div class=\"speaker-meta\"><ul><li>Acting Administrator, CMS<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>1:00 pm - 1:30 pm<\/b><br \/>Bristol-Myers Squibb Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/thomas-lynch-md\/\">Fireside Chat: Giovanni Caforio, MD, CEO, Bristol-Myers Squibb<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Introduction by: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/thomas-lynch-md\/\">Thomas Lynch, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Mass General Physician's Organization<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/meg-tirrell\/\">Meg Tirrell<\/a><\/div><div class=\"speaker-meta\"><ul><li>Biotech and Pharma Reporter, CNBC<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/giovanni-caforio-md-ceo-bristol-myers-squibb\/\">Giovanni Caforio, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Bristol-Myers Squibb<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>1:40 pm - 2:10 pm<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/nancy-l-snyderman-md-2\/\">Fireside Chat: Patients Driving Innovation<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/nancy-l-snyderman-md\/\">Nancy Snyderman, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Medical Advisor, GE Healthymagination<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/kathy-giusti\/\">Kathy Giusti<\/a><\/div><div class=\"speaker-meta\"><ul><li>Founder, Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>2:10 pm - 3:00 pm<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/marcela-maus-md-phd\/\">Immunotherapy II: Cell Based Therapies<\/a><\/h5>\n<p>Oncology sits on the cusp of a new revolution thanks to the use of human cells as versatile<br \/>\ntherapeutic engines. By modifying T cells to express chimeric antigen receptors (CARs) that<br \/>\nrecognize cancer-specific antigens, our expert panelists describe how they have been able to prime<br \/>\ncells to recognize and kill tumor cells that would otherwise escape immune detection. They also<br \/>\ndetail the various \u201cliving drugs\u201d that kill cancer cells and could replace standard oncology<br \/>\ntreatments in the future.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/david-fisher-md-phd\/\">David Fisher, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chief, Dermatology Service, Director, Melanoma Program, Director, Cutaneous Biology Research Center, MGH Cancer Center<\/li><li>Edward Wigglesworth Professor of Dermatology, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/usman-oz-azam-md\/\">Usman (Oz) Azam, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Global Head, Cell & Gene Therapies Unit, Novartis<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/mark-frohlich-md\/\">Mark Frohlich, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Executive Vice President, Portfolio Strategy, Juno Therapeutics<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/marcela-maus-md-phd\/\">Marcela Maus, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Director of Cellular Immunotherapy, Massachusetts General Hospital<\/li><li>Assistant Professor, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/chuck-wilson-phd\/\">Chuck Wilson, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Unum Therapeutics<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>3:00 pm - 3:50 pm<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/jean-francois-formela-md\/\">Financing Breakthrough Cancer Companies<\/a><\/h5>\n<p>The global market for oncology therapies is currently more than $100 billion annually, and could<br \/>\nreach $147 billion by the end of the decade. Panel experts discuss the most compelling<br \/>\ntechnologies, trends driving investment considerations, new models, pricing considerations and<br \/>\nstrategies they use as leading oncology investors in both early stage and established companies.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Introduction by: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/roger-kitterman\/\">Roger Kitterman<\/a><\/div><div class=\"speaker-meta\"><ul><li>Managing Partner, Partners Innovation<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/meg-tirrell\/\">Meg Tirrell<\/a><\/div><div class=\"speaker-meta\"><ul><li>Biotech and Pharma Reporter, CNBC<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/jean-francois-formela-md\/\">Jean-Fran\u00e7ois Formela, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Partner, Atlas Venture<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/jonathan-leff\/\">Jonathan Leff<\/a><\/div><div class=\"speaker-meta\"><ul><li>Partner, Deerfield Management<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/amir-nashat-phd\/\">Amir Nashat, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Managing Partner, Polaris Partners<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/christopher-viebacher-managing-partner-gurnet-point-capital\/\">Christopher Viehbacher<\/a><\/div><div class=\"speaker-meta\"><ul><li>Managing Partner, Gurnet Point Capital<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>4:00 pm - 4:50 pm<\/b><br \/>Astellas Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/theodore-hong-md\/\">Arms Race in Radiation<\/a><\/h5>\n<p>The Holy Grail of radiation therapy is to maximize the effectiveness of killing cancer<br \/>\ncells while minimizing the effect on neighboring tissue. Technology meets modern<br \/>\ncancer care with the integration of technologies that offer enormous benefits to<br \/>\nthe cancer patient in improved quality of life and increased likelihood of<br \/>\ncure. Expert panelists will highlight current benefits of radiation therapies, the<br \/>\nincreasing use of hypofractionated radiation therapy and describe future tools in<br \/>\ndevelopment that will have the potential to dramatically improve outcomes.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Introduction by: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/jonathan-behr-phd\/\">Jonathan Behr, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Market Sector Leader and EIR, Partners Innovation<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/jay-loeffler-md\/\">Jay Loeffler, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chair, Radiation Oncology, Massachusetts General Hospital<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/daphne-haas-kogan-md\/\">Daphne Haas-Kogan, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chair, Deptartment of Radiation Oncology, Brigham and Women's Hosptial and Dana-Farber Cancer Institute<\/li><li>Professor of Radiation Oncology, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/theodore-hong-md\/\">Theodore Hong, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Director, Gastrointestinal Radiation Oncology, Massachusetts General Hospital<\/li><li>Associate Professor of Radiation Oncology, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/joseph-jachinowski\/\">Joseph Jachinowski<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Mevion Medical Systems<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/dow-wilson\/\">Dow Wilson<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Varian Medical Systems<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>4:00 pm - 4:50 pm<\/b><br \/>Bristol-Myers Squibb Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/monica-bertagnolli-md-3\/\">Breakthrough Devices to Treat Cancer<\/a><\/h5>\n<p>The increasing demand for early diagnosis of cancer and the growing prevalence of<br \/>\nmetastatic brain, lung, breast, prostate and other cancers is driving the oncology<br \/>\ndevice market. Our experts zero in on innovative technologies that will address<br \/>\nchallenges in cancer surgery and pain management.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Introduction by: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/monica-bertagnolli-md\/\">Monica Bertagnolli, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chief, Division of Surgical Oncology, Brigham and Women's Hospital<\/li><li>Professor of Surgery, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/antonio-chiocca-md-phd\/\">Antonio Chiocca, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chairman, Neurosurgery, Brigham and Women's Hospital<\/li><li>Professor of Surgery, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/maurice-ferre-md\/\">Maurice Ferre, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Insightec<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/david-lee\/\">David Lee<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Lumicell<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/amy-pollack-md\/\">Amy Pollack, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chief Medical Officer and Vice President of Global Medical Affairs for the Early Technologies Business Group\/Minimally Invasive Technology Innovations (MITG), Medtronic<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/ralph-weissleder-phd-md\/\">Ralph Weissleder, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Director, Center for Systems Biology, Massachusetts General Hospital<\/li><li>Professor, Radiology and Systems Biology, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>4:00 pm - 4:50 pm<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/pat-fortune-phd\/\">Study Designs to Meet the Challenges of Personalized Cancer Medicine<\/a><\/h5>\n<p>Cancer biology indicates that cancer is a large number of niche diseases that may be targeted<br \/>\nwith therapies against specific molecular alterations common to multiple tumor types. This<br \/>\nmodel creates challenges for both drug development and patient care with implications for<br \/>\ninitial indication selection and design and execution of clinical trials \u2013 from first in human<br \/>\nthrough post marketing studies. Among the topics the panel will address:<br \/>\n\u2022 The availability of biomarkers to stratify trials, select patients and monitor drug response can improve<br \/>\nboth trial speed and cost, as well as enable development of companion diagnostics but at the same time<br \/>\npresent more complex validation requirements.<br \/>\n\u2022 Design of trials using surrogate end points holds great promise but validation of such endpoints is a<br \/>\nregulatory challenge. Adaptive trial designs for dose response, pK\/PD and efficacy hold promise but<br \/>\nadoption of such approaches has been slow.<br \/>\n\u2022 Cancer immunotherapies create a significant opportunity for development of combination therapies<br \/>\nbut the cost of acquiring the approved drug can significantly increase the cost of clinical trials. This may<br \/>\nnecessitate new approaches to late preclinical development as well as biomarkers that are early and<br \/>\naccurate indicators of drug response for incorporation in the clinical trial in Phase I\/II.<br \/>\n\u2022 The cost of current and next generation cancer drugs will require measuring clinical and econometric<br \/>\noutcomes in order to justify reimbursement. This may mandate larger post marketing clinical studies,<br \/>\nincluding observational trials<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Introduction by: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/pat-fortune-phd\/\">Pat Fortune, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Senior Market Sector Leader, Partners Innovation<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/gideon-gil\/\">Gideon Gil<\/a><\/div><div class=\"speaker-meta\"><ul><li>Managing Editor, STAT<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/julia-beaver-md\/\">Julia Beaver, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Acting Clinical Team Leader, Division of Oncology Products 1, CDER, FDA<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/maria-koehler-md-phd\/\">Maria Koehler, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Vice President, Strategy, Innovation and Collaborations, Pfizer Oncology Business Unit<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/mike-vasconcelles-md\/\">Mike Vasconcelles, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>CMO, Unum Therapeutics<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>4:00 pm - 4:50 pm<\/b><br \/>Takeda Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/ann-partridge-md\/\">Surviving Cancer: New Realities, New Needs<\/a><\/h5>\n<p>Extraordinary treatment advances have turned many cancers from apparent death sentences<br \/>\ninto manageable chronic illnesses with extraordinary consequences for the entire health<br \/>\ncare system. In the United States, there are approximately 14 million cancer survivors, up from<br \/>\njust three million four decades ago. Those survivors have unique care requirements, that will<br \/>\nput enormous stress on the system &#8212; calling out for new technology solutions. The panel will<br \/>\ndiscuss requirements technologies and approaches that can help monitor, guide, and connect<br \/>\npatients.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Introduction by: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/trung-do\/\">Trung Do<\/a><\/div><div class=\"speaker-meta\"><ul><li>Executive Director, Business Development, Partners Innovation<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/tim-ferris-md\/\">Tim Ferris, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Senior Vice President of Population Health Management, Partners HealthCare<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/jani-ahonala\/\">Jani Ahonala<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Noona Healthcare<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/don-dizon-md\/\">Don Dizon, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Clinical Co-Director, Gynecologic Oncology, Founder and Director, The Oncology Sexual Health Clinic, Massachusetts General Hospital<\/li><li>Associate Professor of Medicine, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/ann-partridge-md\/\">Ann Partridge, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Director, Adult Survivorship Program, Program for Young Women with Breast Cancer, Dana-Farber Cancer Institute<\/li><li>Associate Professor of Medicine, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/claire-thom\/\">Claire Thom<\/a><\/div><div class=\"speaker-meta\"><ul><li>Senior Vice President, Global Oncology Development, Astellas<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>5:00 pm - 6:30 pm<\/b><br \/>General Electric Foyer<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/attendee-reception-2\/\">Attendee Reception<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n\n\n\n<\/div>\n<\/div>\n<h3 id=\"Wednesday, April 27, 2016\">Wednesday, April 27, 2016<\/h3><span id=\"2016-04-27\" rel=\"m_PageScroll2id\"><\/span> \n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>7:30 am - 8:30 am<\/b><br \/>Ipsen Foyer<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/breakfast\/\">Continental Breakfast<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>8:05 am - 8:10 am<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/opening\/\">Opening<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/chris-coburn\/\">Chris Coburn<\/a><\/div><div class=\"speaker-meta\"><ul><li>Vice President, Innovation, Partners HealthCare<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>8:10 am - 9:00 am<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/david-schenkein-md\/\">Combination Cancer Therapies: Drug Resistance and Therapeutic Index<\/a><\/h5>\n<p>Study Designs to Meet the Challenges of Personalized Cancer Medicine Game changing modern<br \/>\ncancer therapies\u2014immunotherapies and targeted therapies, among others\u2014do not by themselves<br \/>\nmeet the needs of many patients who require alternative strategies to achieve optimal therapeutic<br \/>\nbenefit. Panel experts will describe combining these therapies with other drugs, challenges and the<br \/>\npath forward.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/jens-eckstein-phd\/\">Jens Eckstein, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>President, SR One<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/kenneth-anderson-md\/\">Kenneth Anderson, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Director, Jerome Lipper Multiple Myeloma Center, Kraft Family Professor of Medicine, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/jeffrey-engelman-md-phd\/\">Jeffrey Engelman, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Director, Thoracic Oncology and Director, Molecular Therapeutics, Medical Oncology, Massachusetts General Hospital<\/li><li>Laurel Schwartz Associate Professor of Medicine, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/jamie-freedman-md-phd\/\">Jamie Freedman, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Senior Vice President, Global Clinical Development, Medimmune<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/david-schenkein-md\/\">David Schenkein, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Agios Pharmaceuticals<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/william-sellers-md\/\">William Sellers, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Vice President and Global Head of Oncology, Novartis Institutes for BioMedical Research<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>9:00 am - 9:40 am<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/joseph-jimenez\/\">Fireside Chat: Joseph Jimenez, CEO, Novartis<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/gregg-meyer-md\/\">Gregg Meyer, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chief Clinical Officer, Partners Healthcare System<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/joseph-jimenez\/\">Joseph Jimenez<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Novartis<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>9:40 am - 10:30 am<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/michael-pellini-md\/\">Cancer Diagnostics: New Uses, New Reimbursements?<\/a><\/h5>\n<p>Advances in genetics, genomics and proteomics are driving advances in identifying and treating<br \/>\ndisease. Use of genetic testing and molecular diagnostics is rapidly expanding in clinical practice,<br \/>\ncreating a new, personalized approach to medicine. Panelists describe key new technologies and<br \/>\nhow they will be fully integrated into the delivery of care.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/jeffrey-golden-md\/\">Jeffrey Golden, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chair of Pathology, Brigham and Women's Hospital<\/li><li>Ramzi S. Cotran Professor of Pathology, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/1903\/\">Helmy Eltoukhy, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Guardant Health, Inc.<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/marc-grodman-md\/\">Marc Grodman, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Columbia University<\/li><li>Founder, Former CEO, BioReference Laboratories\/GeneDx<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/john-iafrate-md-phd\/\">John Iafrate, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Associate in Pathology, Medical Director, Center for Integrated Diagnostics, Massachusetts General Hospital<\/li><li>Professor of Pathology, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/neal-lindeman-md\/\">Neal Lindeman, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Associate Pathologist, Brigham and Women's Hospital<\/li><li>Associate Professor, Pathology, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/michael-pellini-md\/\">Michael Pellini, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>CEO, Foundation Medicine<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/risa-stack-phd\/\">Risa Stack, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>General Manager, New Business Creation, GE Ventures<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>10:30 am - 11:20 am<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/judy-salerno-md\/\">New Philanthropy: Patients Driving Innovation<\/a><\/h5>\n<p>Philanthropy\u2019s role in driving improved cancer care has evolved rapidly over the<br \/>\nlast decade. Disease foundations have become active in nearly every phase of the<br \/>\ncare spectrum supporting innovations in the lab, clinic, patient engagement, and<br \/>\nregulatory approval among others. Senior philanthropic leaders will describe how<br \/>\nthe foundation community is redefining roles and finding new ways to help<br \/>\npatients as they seek to drive breakthroughs in understanding and care.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\">Introduction by: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/scott-sperling\/\">Scott Sperling<\/a><\/div><div class=\"speaker-meta\"><ul><li>Co-President, Thomas H. Lee Partners<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\">Moderator: <a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/mallika-marshall-md\/\">Mallika Marshall, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Health Reporter, WBZ-TV\/CBS Boston<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/louis-degennaro-phd\/\">Louis DeGennaro, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>President and CEO, The Leukemia & Lymphoma Society<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/judy-salerno-md\/\">Judy Salerno, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>President and CEO, Susan G. Komen for the Cure<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/billy-starr\/\">Billy Starr<\/a><\/div><div class=\"speaker-meta\"><ul><li>Founder and Executive Director, Pan-Mass Challenge<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>11:25 am - 12:25 pm<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/monica-bertagnolli-md-2\/\">Disruptive Dozen<\/a><\/h5>\n<p>Cancer faculty from the Brigham and Women\u2019s Hospital, Massachusetts General<br \/>\nHospital, and Dana-Farber Cancer Institute nominated dozens of technologies that<br \/>\nwill have the greatest impact on cancer care in the next decade, and then compiled<br \/>\na ranking of the 12 most disruptive technologies. A panel of experts will announce<br \/>\nand discuss each of the technologies chosen. This intriguing, informative and fun<br \/>\nsession will let you in on how the experts view the future in their field.<\/p>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/monica-bertagnolli-md\/\">Monica Bertagnolli, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chief, Division of Surgical Oncology, Brigham and Women's Hospital<\/li><li>Professor of Surgery, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/james-brink-md\/\">James Brink, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Radiologist-in-Chief, Massachusetts General Hospital<\/li><li>Juan M. Taveras Professor of Radiology, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/lynn-bry-md-phd\/\">Lynn Bry, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Associate Professor of Pathology, Director, Massachusetts Host-Microbiome Center and Crimson Core, Dept. Pathology, Brigham and Women's Hopsital<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/antonio-chiocca-md-phd\/\">Antonio Chiocca, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chairman, Neurosurgery, Brigham and Women's Hospital<\/li><li>Professor of Surgery, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/jeffrey-engelman-md-phd\/\">Jeffrey Engelman, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Director, Thoracic Oncology and Director, Molecular Therapeutics, Medical Oncology, Massachusetts General Hospital<\/li><li>Laurel Schwartz Associate Professor of Medicine, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/omid-farokhzad-md\/\">Omid Farokhzad, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Physician-scientist, Anesthesiology, Brigham and Women's Hospital<\/li><li>Associate Professor, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/tim-ferris-md\/\">Tim Ferris, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Senior Vice President of Population Health Management, Partners HealthCare<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/daniel-haber-phd-md\/\">Daniel Haber, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Director, MGH Cancer Center<\/li><li>Kurt J. Isselbacher \/Peter D. Schwartz Professor of Oncology, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/keith-joung-md-phd\/\">Keith Joung, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>The Jim and Ann Orr MGH Research Scholar, Associate Chief of Pathology for Research, Pathologist, Massachusetts General Hospital<\/li><li>Professor of Pathology, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/shyamala-maheswaran-phd\/\">Shyamala Maheswaran, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Associate in Molecular Biology, Surgery, Massachusetts General Hospital<\/li><li>Associate Professor, Surgery, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/marcela-maus-md-phd\/\">Marcela Maus, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Director of Cellular Immunotherapy, Massachusetts General Hospital<\/li><li>Assistant Professor, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/carl-novina\/\">Carl Novina, MD, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Associate Professor of Microbiology and Immunobiology, Dana-Farber Cancer Institute & Harvard Medical School<\/li><li>Associate Member, Broad Institute of Harvard & MIT<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/ann-partridge-md\/\">Ann Partridge, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Director, Adult Survivorship Program, Program for Young Women with Breast Cancer, Dana-Farber Cancer Institute<\/li><li>Associate Professor of Medicine, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta --><div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/johnathan-whetstine-phd\/\">Johnathan Whetstine, PhD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Tepper Family MGH Research Scholar<\/li><li>Associate Professor of Medicine, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>12:25 pm - 12:45 pm<\/b><br \/>Ipsen Foyer<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/lunch-break\/\">Boxed Lunches Available<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n\n\n\n<\/div>\n<\/div>\n\n<div class=\"the-event\">\n<div class=\"event-timeloc\"><b>12:25 pm - 12:35 pm<\/b><br \/>Novartis Ballroom<\/div>\n<div class=\"event-details\">\n<h5><a href=\"http:\/\/medforum16.sitedistrict.com\/events\/forum-closing\/\">Forum Closing<\/a><\/h5>\n\n\n<!-- h5>Panelists<\/h5 -->\n<div class=\"speaker-text\"><a href=\"http:\/\/medforum16.sitedistrict.com\/speakers\/anne-klibanski-md\/\">Anne Klibanski, MD<\/a><\/div><div class=\"speaker-meta\"><ul><li>Chief Academic Officer, Partners HealthCare<\/li><li>Laurie Carrol Guthart Professor of Medicine, Harvard Medical School<\/li><\/ul><\/div><!-- end .speaker-meta -->\n\n\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"&nbsp; Anne Klibanski, M.D, is the Chief Academic Officer at Partners HealthCare and the Laurie Carrol Guthart Professor of Medicine at Harvard Medical School.\u00a0 In her role as Partners Chief Academic Officer, she oversees Partners-wide academic programs in research and education including Partners Innovation, Partners Personalized Medicine, Research Computing, Partners IRB, Graduate Medical Education, Continuing <span class=\"continue-link\">...<\/span>","protected":false},"author":2,"featured_media":1602,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"agenda","_genesis_custom_post_class":"","_genesis_layout":"","spay_email":""},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"http:\/\/medforum16.sitedistrict.com\/wp-json\/wp\/v2\/pages\/558"}],"collection":[{"href":"http:\/\/medforum16.sitedistrict.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/medforum16.sitedistrict.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/medforum16.sitedistrict.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/medforum16.sitedistrict.com\/wp-json\/wp\/v2\/comments?post=558"}],"version-history":[{"count":0,"href":"http:\/\/medforum16.sitedistrict.com\/wp-json\/wp\/v2\/pages\/558\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/medforum16.sitedistrict.com\/wp-json\/wp\/v2\/media\/1602"}],"wp:attachment":[{"href":"http:\/\/medforum16.sitedistrict.com\/wp-json\/wp\/v2\/media?parent=558"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}